Zeng Qian, Cai Jiaodi, Wan Hengquan, Zhao Simin, Tan Yao, Zhang Chi, Qu Shunlin
Pathophysiology Department, Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, University of South China, Hengyang, China.
Department of Pathology, The Fourth Hospital of Changsha, Changsha, China.
Clin Chim Acta. 2021 Jul;518:33-37. doi: 10.1016/j.cca.2021.03.011. Epub 2021 Mar 18.
Cardiovascular disease (CVD) is still one of the most significant diseases and is a considerable threat to human health globally. PIWI-interacting RNAs (piRNAs) are novel small noncoding RNAs (ncRNAs) traditionally considered to be specifically expressed in the germline of many animal species and involved in the maintenance of germline stem cells and spermatogenesis. Although little is known about the origin and action of piRNAs and PIWI proteins in somatic cells, these molecules are emerging as readily available biomarkers for the diagnosis and treatment of cardiac injury and multiform CVD. Accumulating evidence reveals that piRNAs and PIWI proteins are associated with some molecular and cellular pathways in CVD. Here, we summarize recent evidence and evaluate the molecular mechanism of the involvement of piRNAs and PIWI proteins in CVD.
心血管疾病(CVD)仍然是最重要的疾病之一,对全球人类健康构成重大威胁。PIWI相互作用RNA(piRNA)是一类新型的小非编码RNA(ncRNA),传统上被认为在许多动物物种的生殖系中特异性表达,并参与生殖系干细胞的维持和精子发生。尽管人们对piRNA和PIWI蛋白在体细胞中的起源和作用了解甚少,但这些分子正逐渐成为心脏损伤和多种心血管疾病诊断与治疗的现成生物标志物。越来越多的证据表明,piRNA和PIWI蛋白与心血管疾病中的一些分子和细胞途径有关。在此,我们总结了近期的证据,并评估了piRNA和PIWI蛋白参与心血管疾病的分子机制。